Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial
| Autor: | Daria Bolsun |
|---|---|
| Rok vydání: | 2019 |
| Zdroj: | Nephrology. :6-15 |
| ISSN: | 2075-3594 |
| DOI: | 10.18565/nephrology.2019.2.06-15 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|